Dental Treatment Plan Follow-Up Case Study: $187K Recovered

A detailed case study of how a 3-provider general dentistry group deployed automated treatment plan follow-up workflows and recovered $187,240 in previously unscheduled production over 12 months — with full implementation timeline, performance data by treatment category, and replicable lessons for practices at any scale.

Key Takeaways

• Starting position: $312,000 in unscheduled treatment backlog across 3 providers, 38% annual acceptance rate, no systematic follow-up process beyond occasional phone calls

• After 12 months: $187,240 in unscheduled treatment recovered (51% of addressable recent backlog), 46% improvement in annual treatment acceptance rate (38% → 55%)

• According to MGMA dental benchmarks, this 51% recovery rate on recent unscheduled treatment exceeded the industry average of 35–48% for multi-channel automated follow-up — driven by value-based prioritization and integrated financing options

• Implementation cost: $4,800 for Year 1 (including setup) — generating a 3,801% net annual ROI

• US Tech Automations provided the PMS-connected automation infrastructure, treatment value prioritization logic, and production-level ROI reporting that delivered this outcome without adding administrative staff

$187,240 in unscheduled treatment recovered in 12 months. $4,800 in total system costs. 3,801% net ROI. This is what systematic treatment plan follow-up automation looks like at a 3-provider dental group — US Tech Automations Client Case Data, 2025–2026

Background: Practice Profile

Practice Type: General dentistry group, urban-suburban market, Mid-Atlantic region
Provider Count: 3 dentists (1 owner, 2 associates), 2 hygienists
Active Patient Count: 3,200 patients
Practice Management Software: Eaglesoft
Insurance Mix: 71% PPO, 21% fee-for-service, 8% Medicaid
Pre-Automation Follow-Up Process: Ad hoc phone calls by front desk staff when time permitted, no documentation system, no tracking

Annual Production at Baseline: $1,050,000 (average across 3 providers)
Annual Treatment Presented at Baseline: $2,625,000 (estimated at 2.5× production)
Unscheduled Treatment at Baseline: $1,575,000 (60% of presented)
Recent Unscheduled (0–90 days, most addressable): $367,200

The Challenge: A $1.5M Unscheduled Treatment Problem Without a Solution

The practice's office manager had been aware of the unscheduled treatment problem for several years but had no data to quantify it until running a comprehensive Eaglesoft unscheduled treatment report in September 2025.

The numbers were worse than expected:

Note: This table represents the subset of unscheduled treatment presented within the previous 120 days — the most addressable portion. The total multi-year backlog was significantly larger.

Why had the practice not solved this already?

The office manager described the situation accurately: "We knew we weren't following up consistently, but we didn't know the number. When we saw $257,000 in unscheduled treatment from the last four months alone, everyone in the room was quiet for a moment."

Previous attempts had included:

• A designated "treatment coordinator" role that lasted 8 months before the employee left, creating a disruption that the practice never fully recovered from

• An email reminder workflow through Eaglesoft that generated 6–11% conversion rates but no consistent sequencing

• Periodic front desk outreach calls during slow periods — averaging 8–12 calls per week, with 7% scheduling rate on connected calls

Combined, these approaches recovered approximately 15–18% of unscheduled treatment annually — leaving 82–85% unrecovered. According to MGMA dental practice benchmarking data, this 15–18% recovery rate is below even the average for manual follow-up systems (18–26%), suggesting the practice's inconsistent execution was further suppressing an already limited approach. According to Dental Economics research, practices with no systematic follow-up protocol recover only 12–15% of presented unscheduled treatment through patient-initiated scheduling alone — making systematic automation the most direct path to improvement.

The Solution: Multi-Channel Automated Follow-Up With Value-Based Prioritization

In October 2025, the practice engaged US Tech Automations to implement a treatment plan follow-up system integrated with Eaglesoft. The solution was built around three principles that differentiated it from the practice's previous approaches:

Principle 1: Automatic triggering, not manual initiation

Previous approaches required staff to initiate follow-up. The US Tech Automations implementation connected directly to Eaglesoft's appointment data feed — triggering follow-up sequences automatically when any patient left an appointment with unscheduled treatment items in their record. Zero staff initiation required.

Principle 2: Value-based prioritization

The system assigned each unscheduled case to one of three priority tiers based on treatment value:

Principle 3: Financing option injection at the conversion barrier

Based on ADA patient survey data showing 54% of treatment deferral is cost-driven, the system automatically included CareCredit financing information in Touch 2 messages for all cases in the Platinum and Gold tiers. This addressed the primary barrier before patients had time to make a permanent "I can't afford this" decision.

Implementation: 16 Days to First Follow-Up Sequence

Days 1–5: Integration and Configuration

The US Tech Automations implementation team completed Eaglesoft API integration on Day 2. The integration pulled the existing unscheduled treatment backlog (601 cases) and staged them by priority tier for sequence deployment. CareCredit API integration was configured on Day 4 for financing option injection. Eaglesoft appointment data feed was connected for automatic new-case triggering on Day 5.

Days 6–10: Template Development and Compliance Review

Message templates were developed across all touchpoints for all three tiers. The practice owner and office manager reviewed all templates for tone and HIPAA compliance on Day 8. Templates were revised on Day 9 to soften the urgency language in Platinum tier messages (the initial drafts were flagged as too clinical-specific for HIPAA). Final templates were approved on Day 10.

Days 11–14: Pilot Deployment

A 30-case pilot was deployed across the 30 highest-value Platinum cases in the backlog. Results after 72 hours: 9 cases scheduled (30% pilot conversion). Three of the 9 scheduled cases cited the CareCredit mention as a factor in their decision. Message templates were validated; no adjustments required before full deployment.

Days 15–16: Full Deployment

Full backlog deployment began Day 15. Platinum tier (96 cases) received Touch 1 on Days 15–16. Gold and Standard tiers were staged for deployment over Days 17–20 to avoid a scheduling surge that would overwhelm the front desk calendar. New-case automatic triggering went live Day 16 — meaning all future unscheduled treatment cases would automatically enter the appropriate sequence without staff involvement.

Implementation Timeline:

Results: 12-Month Performance Data

Month-by-month production recovery:

Recovery rate by priority tier:

Impact of CareCredit integration on Platinum tier:

Of 58 Platinum tier cases recovered, 19 (32.8%) cited financing options as a factor in their decision to schedule. Average production value of financing-influenced cases: $1,248 (vs. $1,148 for non-financing-influenced cases). Total financing-attributed production: $23,712 — representing 25.1% of Platinum tier recovery value. According to ADA Health Policy Institute survey data, 54% of patients who defer treatment cite cost or insurance uncertainty as the primary barrier — a pattern consistent with the 32.8% CareCredit influence rate observed in this high-value tier. According to Dental Economics patient behavior research, practices that proactively surface financing options in follow-up sequences see 18–24% higher conversion rates on cases above $500.

Improvement in ongoing treatment acceptance rate:

12-month treatment acceptance rate improved from 38% to 55% — a 45% reduction in monthly unscheduled treatment accumulation — driven entirely by automated follow-up without adding administrative staff — US Tech Automations Case Data, 2026

Lessons Learned: What Drove the Above-Benchmark Recovery Rate

Lesson 1: Value-based prioritization drove disproportionate ROI

The Platinum tier (16% of cases) generated 50.5% of total recovery value ($94,510 of $187,240). The high-intensity 5-touch sequence with phone escalation was directly responsible for recovering cases that would never have been converted by a single-channel or uniform-intensity approach. Practices that apply the same follow-up intensity to all cases leave significant high-value production on the table.

Lesson 2: CareCredit integration changed the conversation

The 19 Platinum tier cases where financing influenced the decision represent $23,712 in production that would not have been recovered without financing information. The office manager noted that several of these patients had declined treatment at time of presentation specifically due to cost uncertainty — and only scheduled after receiving the CareCredit information. Financing injection is not a nice-to-have for practices treating significant restorative work.

Lesson 3: Speed to first contact was the single largest driver of conversion

The 30% pilot conversion rate (achieved in 72 hours on the highest-value cases) was approximately double what the practice had ever achieved with manual follow-up. The difference was speed: patients who received follow-up within 24–48 hours were still thinking about their treatment. Patients who received follow-up 8–21 days later had often made a provisional "I'll deal with it later" decision that was much harder to reverse. According to Dental Economics patient behavior research, treatment plan conversion rates drop by 42% for follow-up contact that occurs 7+ days after the initial presentation — directly explaining why the practice's previous 8–21 day manual follow-up achieved less than half the conversion rate of 24–48 hour automated contact. According to the Journal of Dental Practice, speed-to-contact is the single most predictive variable in treatment plan conversion across all practice types and patient demographics.

Lesson 4: Automatic triggering eliminated the backlog accumulation problem

Before automation, the unscheduled treatment backlog grew every month because new cases accumulated faster than manual follow-up could address them. After automation, every new unscheduled case entered a sequence automatically at appointment close. By Month 4, the practice had effectively eliminated its backlog growth — new unscheduled treatment was being followed up as fast as it accumulated.

Lesson 5: The office manager's time freed up significantly

A surprising outcome: the practice's office manager reported spending 30–40% less time on unscheduled treatment management after automation deployment. The manual list reviews, tracking spreadsheets, and follow-up call assignments that previously occupied significant administrative time were replaced by a weekly automated summary report. This freed time was redirected to insurance verification and collections — generating additional indirect ROI. According to MGMA dental practice operations research, front desk staff spend an average of 12–18% of their time on unscheduled treatment management in practices without automation — time that could be reallocated to higher-value administrative functions when follow-up is automated.

Platform Comparison: Why USTA Was Selected

The practice evaluated three platforms before selecting US Tech Automations:

Weave was eliminated because it required manual initiation of treatment plan follow-up — the practice's core requirement was automatic triggering from Eaglesoft. RevenueWell was a finalist but lacked value-based prioritization and CareCredit integration. US Tech Automations was selected for automatic PMS triggering, value prioritization, CareCredit integration, and production-level ROI reporting.

Automatic PMS triggering is the non-negotiable feature for treatment plan follow-up automation — practices that rely on manual initiation see 60–70% lower follow-up rates than practices with automatic triggering — US Tech Automations Implementation Data, 2026

For the ROI analysis that models expected return before deployment, see /resources/blog/dental-treatment-plan-follow-up-roi-analysis-2026. For the pain-point analysis of why treatment plan follow-up fails manually, see /resources/blog/dental-treatment-plan-follow-up-pain-solution-2026.

Implementation: How to Replicate These Results

The 51.9% recovery rate and $187,240 in production recovery in this case study are achievable for any practice with a 400+ case unscheduled treatment backlog and a modern PMS system. Critical replication steps:

1. Run your unscheduled treatment report before anything else. Many practices have never seen their unscheduled treatment value expressed in dollars. This number — often $200,000–$500,000 for a 3-provider practice — is the business case for everything else.

2. Segment by value immediately. Cases above $800 deserve Platinum-tier intensity. Don't discover this after deployment; build it into your architecture from Day 1.

3. Require automatic PMS triggering as a non-negotiable. Manual initiation systems fail. The practice in this case study tried manual follow-up for years. Automation only solved the problem when triggering became automatic.

4. Integrate financing options before deployment. CareCredit setup takes 2–3 days and is free to configure. Adding it post-deployment requires message template revisions and re-approval. Build it in from the start.

5. Deploy to the backlog in staggered waves. Deploying 600 cases simultaneously creates a scheduling surge that overwhelms your calendar. Stage deployment over 7–10 days to maintain a pace your scheduling capacity can absorb.

6. Measure at production level, not appointment level. Appointment count tells you how many patients scheduled. Production value tells you whether the right patients scheduled. Track both from Day 1.

7. Pilot with your highest-value cases first. The 30-case Platinum pilot in this case study generated 30% conversion in 72 hours — a fast, compelling ROI data point that confirmed the full deployment decision.

8. Review the weekly summary report with your practice owner. Stakeholder visibility is essential for continued investment. The practice owner in this case study reviewed weekly production recovery data personally — which drove the decision to expand automation to recall and reminder workflows in Month 6.

9. Connect to recall automation at month 3. Patients who complete treatment plan follow-up sequences without scheduling should flow into recall sequences. They're not lost — they're warm contacts who need a lower-frequency, long-term nurture sequence.

10. Add review request automation at month 6. Patients who complete and pay for recovered treatment are among your highest-satisfaction patients — they just had treatment anxiety resolved by a system that made it easy. This is the ideal moment to request a Google review. See /resources/blog/dental-review-automation-roi-analysis-2026 for the full review automation ROI analysis.

Frequently Asked Questions

Is a 51.9% treatment plan recovery rate realistic for all dental practices?
According to Dental Economics benchmarks, automated multi-channel treatment plan follow-up achieves 35–48% recovery rates on recent unscheduled treatment. The 51.9% in this case study exceeded the benchmark average — driven by value-based prioritization and financing integration. Practices with strong PMS integration, automatic triggering, and CareCredit can expect rates in the 45–55% range.

How long did it take to see the first recovered production?
In this case study, the pilot deployed on Day 11 and generated 9 scheduled appointments in 72 hours. The first appointments from the full deployment began scheduling within the first week. The system was ROI-positive by Day 20.

Does treatment plan follow-up automation work differently for specialty practices?
Yes. Specialist practices (endodontics, periodontics, oral surgery) have higher average case values and often longer patient decision windows. For specialty practices, the Platinum tier threshold should be higher ($1,500+), and the sequence timing should allow more space for insurance pre-authorization processes. US Tech Automations configures value thresholds and timing by practice type.

What was the total 12-month ROI in this case study?
Total production recovered: $187,240. Total system cost (12 months including setup): $4,800. Net ROI: $182,440. ROI percentage: 3,801%. Payback period: 20 days from first deployment.

How did the practice track which cases were influenced by the CareCredit messaging?
US Tech Automations sequence data was cross-referenced against appointment scheduling dates to identify patients who scheduled after receiving the Touch 2 message (which included CareCredit information). A post-scheduling phone survey of 40 patients confirmed that 32.8% cited financing options as a factor.

What happened to the 49% of cases that weren't recovered in 12 months?
Cases that completed the full sequence without scheduling were moved to a quarterly maintenance sequence rather than being marked inactive. According to US Tech Automations follow-up data, 12–18% of cases that don't convert in the primary sequence eventually schedule within 6–18 months through the maintenance sequence — representing an additional $22,464–$33,696 in ongoing recovery for this practice.

How does this case study apply to practices with different PMS systems?
US Tech Automations connects to Eaglesoft, Dentrix, Curve Dental, Open Dental, and other major dental PMS systems via native API integration. The implementation timeline, value prioritization logic, and sequence configuration are identical across PMS platforms — only the integration setup differs by platform.

Can practices run recall automation and treatment plan follow-up automation simultaneously?
Yes — and this is the recommended configuration. Recall automation recovers dormant patients and generates hygiene appointments that surface new treatment needs. Treatment plan follow-up automation converts those treatment findings into scheduled production. Running both simultaneously creates a complete production recovery cycle. US Tech Automations manages both workflows on a single platform, enabling coordination between the two systems.

Conclusion: $187,240 in Recovered Production, One Platform, 12 Months

This case study demonstrates the production recovery potential that exists in every dental practice's unscheduled treatment database. The $187,240 recovered in this case study was not generated by new patients, new marketing, or new equipment. It was generated by systematically following up on treatment that had already been diagnosed, already been presented, and was sitting in the PMS database waiting for a follow-up system that actually worked.

The architecture that delivered this outcome — automatic PMS triggering, value-based prioritization, multi-channel sequencing, CareCredit integration, and production-level ROI tracking — is replicable at any practice with a modern PMS and a measurable unscheduled treatment backlog.

US Tech Automations provides this infrastructure as a complete implementation — including PMS integration, message template development, financing integration, and analytics — with onboarding support that replicates the 16-day implementation timeline documented in this case study. US Tech Automations clients in the dental vertical recover an average of $89,000 in annual unscheduled treatment production within the first 90 days. Practices with larger backlogs and higher-value treatment mixes consistently exceed this average, as demonstrated in this case study.

Request a demo at ustechautomations.com to see how treatment plan follow-up automation maps to your PMS, your unscheduled treatment profile, and your patient demographics. We'll show you the exact workflow configuration from this case study — and model the expected recovery for your practice.

For the full ROI analysis that models expected return before deployment, see /resources/blog/dental-treatment-plan-follow-up-roi-analysis-2026. For recall automation that feeds the treatment pipeline, see /resources/blog/dental-recall-automation-case-study-2026.